Preferential mobilization of leukemia precursors from the bone marrow into peripheral blood by the CXCR4 inhibitor AMD3100 in a mouse model
Más información
Fecha de publicación: | 2009 |
Objetivos: | 1. To study if AMD3100, AMD11070 and GCSF interrupts leukemia/stroma interaction in-vitro. 2. To study the impact of AMD3100, AMD11070 and GCSF in APL cell cycle status in-vitro. 3. To study the role of SDF-1, AMD3100, AMD11070 and GCSF in chemotherapy induced apoptosis. |
Instrumento: | International grant |
Año de Inicio/Término: | 2009-2013 |
Financiamiento/Sponsor: | Pharmaceutical Company Genzyme |
Rol del Usuario: | Co-investigador |
DOI: |
Genzyme |
Notas: | Proyecto Internacional con la empresa farmacéutica Genzyme |